Sign in
XAIR Stock Price, Chart, Stats & News
Beyond Air, Inc.
Save
1.86M
Market cap
–
Current P/E
–
Forward P/E
XAIR chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 1.82% |
Operating margin | -419.53% |
Pretax margin | -462.58% |
Net margin | -447.73% |
Effective tax rate | – |
ROA | -84.30% |
ROE | -279.58% |
D/E | 3.06x |
Interest coverage ratio | -10.17x |
XAIR valuation
P/E | – |
P/S | 0.53x |
P/B | 0.77x |
P/CF | -0.31x |
P/FCF | -0.17x |
P/OCF | -0.31x |
PEG | -0.01x |
EV multiple | 0.32x |
About
Beyond Air, Inc. functions as a specialized entity involved in both the development of medical devices and biopharmaceutical solutions. A central part of its operations is the LungFit platform, an innovative system that generates and delivers nitric oxide. Within this platform, LungFit PH is currently available, used to address persistent pulmonary hypertension in infants.
Similar securities
Based on sector and market capitalization
Report issue